STALEY CAPITAL ADVISERS’s Innoviva INVA Stock Holding History

STALEY CAPITAL ADVISERS’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-45,471	Closed	-$793K	–	175
2018 Q4	$793K	Hold	45,471	–	–	0.06%	96
2018 Q3	$693K	Hold	45,471	–	–	0.05%	95
2018 Q2	$627K	Buy	45,471 +32,664	+255%	+$489K	0.05%	101
2018 Q1	$213K	Hold	12,807	–	–	0.02%	143
2017 Q4	$182K	Hold	12,807	–	–	0.01%	159
2017 Q3	$181K	Hold	12,807	–	–	0.01%	157
2017 Q2	$164K	Buy	+12,807	New	+$161K	0.01%	160

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

STALEY CAPITAL ADVISERS's INVA Position: Q1 2019 in Review

STALEY CAPITAL ADVISERS sold out of Innoviva (INVA) in Q1 2019, closing a stake of 45,471 shares — an estimated $793K sold.

STALEY CAPITAL ADVISERS first reported a position in INVA in Q2 2017 and held it in 7 quarters. The position peaked at $793K in Q4 2018. 234 funds tracked by Wall St. Rank hold INVA as of Q1 2019.

STALEY CAPITAL ADVISERS reported no remaining Innoviva position as of Q1 2019 after selling out during the quarter.
STALEY CAPITAL ADVISERS sold 45,471 Innoviva shares in Q1 2019, an estimated $793K.
STALEY CAPITAL ADVISERS first reported a position in Innoviva in Q2 2017 and held it in 7 quarters.
STALEY CAPITAL ADVISERS's Innoviva position peaked at $793K in Q4 2018.
234 funds tracked by Wall St. Rank held Innoviva as of Q1 2019.

Based on STALEY CAPITAL ADVISERS's 13F filing for Q1 2019, filed 10 May 2019.